Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first ...
Thesportstak on MSN
Vaibhav Sooryavanshi isn't professional, I ask him not to: RCB star's big revelation ahead of IPL 2026
Jitesh Sharma lavished immense praise on Vaibhav Sooryavanshi's batting prowess but didn't shy away from mentioning the the ...
Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its ...
Earendil Labs has raised an impressive $787 million in financing for its AI-powered drug discovery and development platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results